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Abstract
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Poly (ADP-Ribose) Polymerase I (PARP-1) is a first responder to DNA damage repair and
participates in the regulation of gene expression. The interaction of PARP-1 with chromatin and
DNA is complex and involves at least two different modes of interaction. In its enzymatically
inactive state, PARP-1 binds native chromatin with similar affinity as it binds free DNA ends.
Automodification of PARP-1 affects interaction with chromatin and DNA to different extents.
Here we describe a series of biochemical and biophysical techniques to quantify and dissect the
different binding modes of PARP-1 with its various substrates. The techniques listed here allow for
high throughput and quantitative measurements of the interaction of different PARP constructs
(inactive and automodified) with chromatin and DNA damage models.

Keywords
PARP-1; HIFI-FRET; Job Plot; electrophoretic mobility shift assays; multi-angle light scattering;
analytical ultracentrifugation; atomic force microscopy; small angle x-ray scattering
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1. Introduction
The Poly (ADP-Ribose) Polymerase (PARP) family is a diverse protein family involved in
many cellular processes. PARP-1, the most abundant member of this family, is implicated in
the regulation of gene expression and in the DNA damage response through its ability to
bind tightly to many models of DNA damage (1) as well as interact with undamaged
chromatin (2, 3). In its inactive state, PARP-1 functions as a chromatin architectural protein
that condenses chromatin (4). In vitro, PARP-1 binds native chromatin templates lacking
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exposed DNA ends with nanomolar affinity, comparable to its affinity for various models of
DNA damage (3). Upon enzymatic activation stimulated by DNA damage or other cues,
PARP-1 modifies primarily itself and this affects its interaction with native chromatin much
more than its interaction with free DNA ends. The ability of PARP-1 to bind native and
damaged chromatin may involve different modules of the five known DNA binding domains
in PARP-1 (Fig. 1A): three DNA binding zinc finger domains, a BRCA C-terminus fold
(BRCT), a tryptophan-glycine-arginine (WGR) rich domain, and a catalytic domain
composed of a helical domain (HD) and the ADP-ribosyl transferase (ART) domain. In its
PARylated form, automodified PARP-1 gains a histone chaperone function with the ability
to bind histones with low nanomolar affinity, and assemble nucleosome (3)

Author Manuscript
Author Manuscript

In this chapter, we apply various approaches to measure the interaction between PARP-1
(and truncated variants) and chromatin constructs. While we focus primarily on PARP-1,
these techniques can be utilized for all three DNA-dependent Parps (Parp1-3). PARP-1
proteins were purified as previously described (5, 6), increasing the final NaCl concentration
in the gel filtration buffer to 500 nM. The chromatin templates used here represent both
native and ‘damaged’ chromatin. Mononucleosomes are assembled on the 601 positioning
sequence at varying lengths (see (7, 8) for details on assembly and reconstitution) (Fig. 1B).
The 146 base pair DNA length represents the minimal nucleosome assembly length with no
DNA linker arms. 165 base pair DNA yield mononucleosomes with 7 and 11 extending base
pairs; and 207 base pair has 30 base pairs of linker DNA extending symmetrically. For
higher order chromatin templates, we assembled trinucleosomes on three repeats of the
‘601’ nucleosome positioning sequence (9). The non-linker ended trinucleosome (NLE-Tri)
has 60 base pairs flanking the central nucleosome with no extending DNA linker ends (Fig.
1B). To distinguish interactions between free DNA and chromatin templates, trinucleosome
assembly saturation is ensured via analytical ultracentriguation and restriction enzyme
digestion as described (3, 10). Nuc146 and NLE-Tri represent native chromatin templates,
while Nuc165 and Nuc207 represent double strand breaks in the context of chromatin.

Author Manuscript

The protocols described below allow for the quantification of the in vitro interaction of
PARP-1 with chromatin in solution. We establish a protocol for fluorescently labeling
PARP-1 that does not interfere with or affect automodification activity or nucleosome
binding. Fluorescently labeled PARP-1, in conjunction with fluorescently labeled histones,
nucleosomes, or DNA can be used to quantify apparent binding affinities and complex
stoichiometries through the use of high-throughput interactions by fluorescent intensity with
fluorescent resonance energy transfer (HI-FI FRET) and Job plot stoichiometry
measurements (3, 5). Solution-state HI-FI FRET experiments can be complemented by
electrophoretic mobility shift assays (EMSA). For solution state measurements with
unlabeled substrates, multi-angle light scattering (MALS) and analytical ultracentrifugation
(AUC) provide further information on PARP-1 chromatin complexes by yielding molecular
weights, stoichiometries, and shape information. Lastly, atomic force microscopy (AFM)
and small angle x-ray scattering (SAXS) provide low resolution shape and size information
for PARP-1/chromatin constructs.
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2. Materials
2.1 Automodification of PARP-1
•

Activity buffer: 50 mM Tris-HCl (pH 8.0), 100 mM NaCl, 1 mM MgCl2

•

NAD+ (15 mM stock in activity buffer or H2O)

•

PJ34 hydrochloride (10 mM stock in DMSO) (Sigma Aldrich)

•

Standard SDS-PAGE equipment, denaturing PAGE (e.g. 8% SDS-PAGE)

•

Low binding Eppendorf

2.2 Fluorescent labeling of PARP-1

Author Manuscript
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•

Rotating device at 4°C (e.g. Thermo Scientific Labquake™)

•

Centrifuge equipped with a rotor for holding 50 mL conical tubes (e.g. Beckman
Coulter Allega 21R centrifuge)

•

25 mL vivaspin concentrators (30- to 50- kDa MW cut off)

•

Nanospec or any other spectrophotometer

•

Standard SDS-PAGE equipment, denaturing PAGE (e.g. 15% SDS-PAGE)

•

Typhoon Trio imager (GE Healthcare)

•

ImageQuant TL software for visualizing

•

Maleimide reactive dyes (Alexa488 or Atto-647N) in 10 mM stock in dimethyl
sulfoxide (DMSO) or dimethyl fluoride (DMF); freshly made or frozen at −20°C

•

Labeling Buffer: 25 mM HEPES (pH 8.0), 500 mM NaCl, 0.1 mM EDTA, 0.1
mM TCEP

2.3 Electrophoretic Mobility Shift Assay (EMSA)
•

PAGE equipment at 4°C, 5% native TBE-PAGE

•

Agarose gel running equipment at room temperature

•

Parp Binding Buffer (PBB50 or PBB200): 25 mM Tris-HCl (pH 7.5), 50 or 200
mM NaCl, 2 mM Arginine

•

Low binding Eppendorf tubes

Author Manuscript

2.4 HI-FI FRET & Job Plot
•

Typhoon Trio imager (GE Healthcare)

•

ImageQuant TL for visualization and quantification

•

GraphPad Prism software for data analysis

•

Multi-channel (12 channels) pipette (100 µL)
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•

384-well black Sensoplate Plus with glass flat bottom (Greiner Bio-One
International)

•

96-well block (250 or 500 µL)

•

1% (v/v) Hellmanex in H2O

•

Freshly made Sigma Cote (98% Heptane (Sigma Aldrich), 2% 1, 7
Dichlorooctamethyl-tetrasiloxane (Sigma Aldrich))

•

Microplate binding buffer: 25 mM Tris-HCl (pH 7.5), 200 mM NaCl, 0.01%
NP-40, 0.01% CHAPS

2.5 Size Exclusion Chromatography Multi-Angle Light Scattering (SEC-MALS)

Author Manuscript

•

Wyatt Instruments HELEOS and rEX detectors outfitted with ASTRA software

•

GE Healthcare HPLC

•

SEC column (e.g. S200 increase 10/300 GL (24 mL) (GE Healthcare))

•

PBB200 buffer: 25 mM Tris-HCl (pH 7.5), 200 mM NaCl, 2 mM Arginine,
filtered through a 0.1 µm membrane

•

Bovine serum albumin (BSA; 2 mg/mL (Sigma Aldrich Protein Standard))

2.6 Analytical Ultracentrifugation (AUC)

Author Manuscript

•

AUC cells with quartz windows (Beckman)

•

Proteome Lab XLA or XLI analytical ultracentrifuge

•

Computer with Ultrascan III installed for data analysis and access to Laboratory
Information Management System (LIMS) for 2 dimensional spectrum analysis
(2DSA) and genetic algorithm coupled with Monte-Carlo analysis (GA-MC)
calculations

•

Buffer: 20 mM Tris-HCl (pH 7.5), 1 mM EDTA, 1 mM DTT, or any other buffer

2.7 Atomic Force Microscopy (AFM)

Author Manuscript

•

Asylum Research MFP-3D Atomic Force Microscope or comparable instrument

•

Olympus 240TS AFM tips, or comparable brand

•

Freshly cleaved mica discs (SPI Supplies) glued to glass slides (VWR)

•

3-aminopropyltriethoxysilane (APTES) (Sigma Aldrich)

•

Syringe filters and Syringes or Steriflips

•

Sample buffer: 20 mM Tris-HCl (pH 7.5), 1 mM EDTA, 1 mM DTT, filtered
through a 0.2 µm membrane

2.8 Small Angle X-ray Scattering (SAXS)
•

Synchrotron beamline with SAXS data collection capabilities preferably with inline SEC. All data in the present work was collected at Sector 18ID (BioCAT)
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located at Advanced Photon Source located in Argonne National Laboratory,
Chicago.
•

Size exclusion column (e.g. Superose 6 or Superdex 200 (GE Healthcare))

•

GE Healthcare FPLC or HPLC system

•

Sample buffers: 25 mM Tris-HCl (pH 7.5), 2 mM Arginine, 50 mM NaCl and 20
mM Tris-HCl (pH 7.5), 1 mM EDTA, 1 mM DTT, filtered via 0.2 µm membrane

3. Methods
3.1 Automodification of PARP-1

Author Manuscript

PARP-1 is purified as described (6) with extra precaution taken to ensure the protein prep is
free from DNA (monitor the 260/280 nm ratio closely and keep below 0.6). To study
differences between unmodified and automodified PARP-1 in its chromatin interacting
properties, precautions must also be taken to keep unmodified and automodified Parp
reaction components the same. If done properly, any difference in interactions can be
ascribed to PARylation rather than a reaction component (i.e. DNA, NAD+, or PJ34). To
accomplish this, we utilize a pre-quenched PARP-1 sample (pQ-PARP-1, quenched with
PARP-1 inhibitor, PJ34, prior to the addition of activating DNA and NAD+) as the
unmodified control. To prepare automodified PARP-1, PJ34 is added after a two-hour
incubation with DNA and NAD+ (Fig. 1C). Automodification of PARP-1 (AM-PARP-1)
causes a high molecular weight smear or a shifted band on a denaturing gel due to the
heterogenous nature of PARylation (Fig. 1D, left panel).

Author Manuscript

1.

Set up the pre-quench (pQ) PARP-1 reactions by adding 1 µM PARP-1 to activity
buffer. Incubate with 1 mM PJ34 (final) for 5 minutes (See Note 1).

2.

Add 100 nM DNA (53 bp DNA used here) and incubate at RT for 10 minutes
followed by the addition of NAD+ (600 µM).

3.

Set up the automodification (AM) PARP-1 reaction by incubating PARP-1 (1
µM) and DNA (100 nM) for 10 minutes at RT.

4.

Add 600 µM NAD+ and incubate for 2 hours at RT. Quench reaction with 1 mM
PJ34.

5.

Run pre-quenched and automodification reactions on a denaturing gel (e.g.
Biorad Mini-PROTEAN TGX pre-cast gel, shown here). Higher molecular
weight smearing and disappearance of a single protein band on the gel is
indicative of PARylation (Fig. 1D, left panel).

Author Manuscript

3.2 Fluorescent Labeling PARP-1
Here, maleimide fluorophores (such as Alexa488 or Atto-647N) are chemically conjugated
to native cysteines on PARP-1. The fluorophore is added in an equimolar ratio to PARP-1
and incubated in the dark for 30 minutes. Excess fluorophore is removed through buffer
1The highest concentration recommended for a PARP-1 automodification reaction is 2 µM; the maximum incubation time with NAD+
is overnight.
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washes and labeling efficiency is calculated. PARP-1 can label at multiple locations (e.g.
Cys-24, Cys-256, Cys-429; (5) and data not shown), so 0.1 mM TCEP in the labeling buffer
can help quench the labeling process to prevent over-labeling. Mass spectrometry can be
used to identify which specific residues are labeled. Once labeled, PARP-1 is run on a
denaturing PAGE and stained for protein (0.5–1 µg PARP-1) (Fig. 1D, middle panel) or
scanned on a phosphorimager at the appropriate wavelength to check for fluorescence (0.25–
0.5 µg PARP-1; Fig. 1D, right panel). Compared to unlabeled PARP-1 samples (Fig. 1D, left
panel), Alexa488 labeling (Fig. 1D, middle panel) does not affect electrophoretic mobility or
automodification activity. Here, the difference in PARylation between the unlabeled and
labeled PARP-1 is due to differing times of incubation (unlabeled: 1 hour; labeled: 2 hours).
The automodification reaction time will influence if the PARylation modification appears as
a smear or as a shifted band. Fluorescently labeled PARP-1 can be used in FRET binding
assays and Job plot stoichiometry measurements as described in the next section.

Author Manuscript
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1.

Add equimolar (1 to 1) ratio of fluorophore to protein in a low binding
Eppendorf tube (See Note 2).

2.

Wrap the tube in aluminum foil and rotate in the dark at 4°C for 15 minutes.

3.

Add labeled protein to a 15 mL falcon concentrator (e.g. 50 kDa MW cutoff for
PARP-1).

4.

Add 1–2 mL of labeling buffer for each buffer exchange (See Notes 3 and 4).

5.

Spin concentrator at 4000 k for 10–15 min.

6.

Repeat steps 4 and 5 until flow through is colorless to the eye. Then repeat 1–`2
more times.

7.

Determine the concentration of the protein and dye by absorbance. Labeling
efficiency is calculated by determining the ratio of dye molarity to protein
molarity (See Note 5).

8.

Analyze 0.25–0.5 µg of the labeled protein on a 15% SDS-PAGE (or other
denaturing PAGE). Scan gel at the Typhoon at the proper wavelength to confirm
fluorescent labeling, then stain for protein. Increase sample size to 1 µg for
protein stain (or alternately use a sensitive method of protein detection like silver
stain) if checking for degradation or staining automodified PARP-1 reactions
(Fig. 1D).

9.

Flash freeze in 5–10 µL aliquots in liquid nitrogen and store at −80°C (See Note
6).

Author Manuscript

2For labeling buffer, use the buffer the protein was last in – typically the gel filtration buffer. Protein concentration for labeling can
range from 20–100 µM.
3Other Parp family members such as PARP-2 label more efficiently with Oregon Green 488 iodoacetamide, not Alexa488 maleimide,
for donor fluorophore. You may need to try various fluorophores.
4Always add fresh reducing agent such as pH-adjusted TCEP (not DTT), to the labeling buffer.
5We typically achieve 50–80% labeling efficiency. If over-labeling (100% or more) occurs, continue with buffer washes or run sample
over a PD10 column, then decrease fluorophore concentration and/or incubation time for future labeling experiments.
6Thaw each aliquot once and use within 1–2 days.
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For a qualitative approach to Parp complex formation with DNA and/or nucleosomes,
electrophoretic mobility shift assays are performed (3, 11). Purified Parp proteins (e.g.
PARP-1 or N-Parp) are titrated against reconstituted mono- or trinucleosomes and incubated
overnightat 4°C. Mononucleosome complexes are analyzed by native PAGE and stained for
DNA and protein (Fig. 1E). Fluorescently labeling PARP-1 and nucleosomes (647-Nuc165,
Fig. 1E, lanes 7– 10) does not affect their respective mobility or complex formation when
compared to unlabeled reagents (Fig. 1E, lanes 3–6). Trinucleosome-Parp complexes are run
on a 1% agarose gel and also stained for DNA with Ethidium Bromide and protein with
Imperial protein stain (Fig. 1F). Although in theory, binding constants can be derived from
this approach, this technique is not accurate and other more quantitative approaches are
needed. However, analysis of material prior and after analysis by any of the other
approaches listed below will yield valuable verification that indeed complex formation was
being measured.
1.

Mononucleosomes or DNA are titrated with increasing molar ratios of PARP-1
(or PARP-1 mutant proteins) in PBB50 or PBB200 (See Notes 7–8).

2.

Reactions are incubated overnight at 4°C.

3.

5 µL aliquot of the reaction mix is analyzed on a 5% (w/v) native TBE-PAGE at
4°C at 150 V for 60 min. for mononucleosomes and DNA. For trinucleosome
complexes, see Note 9.

4.

Gels are stained with ethidium bromide followed by Imperial protein stain to
visualize for DNA and protein respectively (Fig. 1E and 1F).

Author Manuscript

3.4 HI-FI FRET Binding Assay & Job Plot Stoichiometry Measurement
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High-throughput interactions by fluorescent intensity with fluorescent resonance
energytransfer (HI-FI FRET) provides a highly sensitive and in solution assay for measuring
apparentbinding affinities of Parp with a variety of substrates (e.g. mononucleosomes,
trinucleosomes, DNA) (3, 5, 12, 13). The assay is schematically represented in Fig. 2A, top
panel. Here, acceptorlabeled ligand (e.g. Nuc165; Fig. 2A, bottom panel) is titrated from 0
nM to 1000 nM. Donorlabeled Parp (e.g. PARP-1; Fig. 2B, bottom panel) is held constant at
low nanomolarconcentrations. If a binding event occurs, the donor fluorophore will be
within Forster distanceof the acceptor fluorophore and thus energy transfer can occur (i.e. a
FRET signal is observed).The FRET signal can be mathematically corrected to quantify
apparent binding affinities. Forexample, PARP-1 binds nucleosomes with linker arms
(Nuc165) with low nanomolar affinity, while nucleosomes with no linker arms, such as
Nuc146, exhibit weak (> 500 nM) affinity andno saturatable plateau (Fig. 2B) (also seen
with Sf9 expressed PARP-1, (3, 5)).

7The arginine in the binding buffer is optional and doesn’t affect the mobility shift.
8Complexes are typically set up at ~1–1.5 µM nucleosome; PARP-1 or N-Parp are titrated between 0.6–1.2 excess over the
nucleosome.
9Trinucleosomes and their complexes are analyzed on a 1% agarose gel in 1× TAE buffer at 50 V for 2 hours at room temperature.
Gels were stained as described.
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To study the effect of PARP-1 automodification on its interactions with various substrates,
pre-quenched and automodified PARP-1 probes were prepared (Fig. 1C). The pre-quenched
and automodified PARP-1 probes both contain low nanomolar amounts of DNA as well as
excess NAD+ and PJ34 in each sample. Comparing the pre-quenched to PARP-1 reactions to
PARP-1 without these components proved that these additional reaction components do not
affect the apparent KD (3). However, PARylation weakens PARP-1 binding to NLE-Tri by a
factor of 20 (Fig. 2D) (3).

Author Manuscript

HIFI-FRET can be paired with Job plot continuous variation measurements to elucidate the
stoichiometries ((14), and applied to PARP-1 in (3)). Here, the amount of donor labeled
PARP-1 is increased in incremental titration steps while the acceptor labeled ligand (e.g.
Nuc165 or dsDNA) is decreased in similar steps (see schematic in Fig. 2D, top panel). This
process keeps the overall molar ratio equal to 1 and therefore, the peak of the analyzed curve
will yield the ideal (peak) molar ratio (Parp:Nuc165 or Parp:DNA). In this example, a
titration of PARP-1 against Nuc165 yields a peak at 0.5, indicating a stoichiometry of one
PARP-1 molecule per mononucleosome (Fig. 2C, black curve). PARP-1 binds DNA in a 2 to
1 ratio indicated by the peak at 0.66 (0.66 PARP-1 per 0.33 DNA) (Fig. 2C, gray curve). Job
plots quantitatively identify a variety of stoichiometries ranging from 1 to 1 (n to n), 2 to 1,
or 1 to 2, etc. A caveat of Job plot is that a peak at a 0.5 molar ratio is consistent with 1:1 or
2:2 (or n:n) stoichiometry, and hence other methods are needed to distinguish between these
possibilities. Thus, results should be verified by SEC-MALS or AUC. These two approaches
also reveal any problems with homogeneity and mono-dispersity of any given complex.
3.4.1 HIFI-FRET Microplate Treatment

Author Manuscript

1.

Fill each well of the 384-well plate with 1% Hellmanex and incubate for 15–20
min.

2.

Rinse the plate thoroughly with distilled water. Repeat rinses 4×.

3.

Let plate dry overnight.

4.

Fill each well with freshly made homemade sigma cote in a well ventilated hood.

5.

Once each well is filled, rinse plate 4× with distilled water.

6.

Let plate dry overnight. Treated microplates can be stored for 2–3 months in
bubble wrap to prevent dust from getting into the wells.

3.4.2 HIFI-FRET Plate Set Up

Author Manuscript

1.

Clean the glass of the microplate with H2O, then 100% EtOH, followed by H2O
again, wipe dry using lint-free kimwipes.

2.

In a 96-well plate, label two rows 1–23 (odd numbers in row A and even
numbers in row B).

3.

Ligand titration series are set up at a concentration 2× the final concentration.
Final titration concentration depends on the KD (See Note 10).

10The titration series should have a final concentration ~10–20-fold greater than the expected K .
D
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4.

Serially diluted master stock concentrations are set up (ex: 1000 nM, 500 nM,
100 nM).

5.

Ligand titration set up by adding buffer to each well followed by ligand and
mixing thoroughly. The first two titration points should always be buffer-only (0
nM ligand).

6.

Parp probe concentrations are decided based on the apparent KD. If the apparent
KD is not 5× below [P], you cannot rely on the single site binding equation
which assumes P exists in two states: free and bound. If [P] ≥ KD, all of the
probe will be bound (FB = 100) and therefore, the assumption is false. In these
cases, the quadratic equation with two or three probe concentrations must be
used to eliminate this assumption. See Equation 1 and Note 11.

Author Manuscript

Equation 1
7.

Probe concentrations are set up 2× the final concentration and at a volume of
1500 µL.

8.

20 µL of the acceptor titration is set up in duplicate for acceptor only and each
FRET series. 20 µL of microplate binding buffer is added to the acceptor only
lanes. Each Parp probe (20 µL) is then added in duplicate to each FRET series.
The total volume in each well is 40 µL.

3.4.3 HIFI-FRET Automodification Binding Plate Set Up
1.

Author Manuscript

Repeat steps 1–8 for the unmodified binding assay set up with a minor change:
for automodified binding assays, two types of probes will be set up, a pre-quench
probe and an automodified probe (see schematic for reaction set up in Fig. 1C
and protocol for automodified PARP). Again, probe concentrations will depend
on apparent KD, as discussed above.

3.4.4 HIFI-FRET Plate Scanning
1.

Clean typhoon glass with 70% EtOH followed by H2O

2.

Scan the plate at 200 µm with +3 mm plane at the following wavelengths and
voltages (See Note 12).

Author Manuscript

3.

•

Acceptor Channel (A): Ex/Em: 633/670 nm; PMT: 400 V

•

Donor Channel (D): Ex/Em: 488/520 nm; PMT: 420 V

•

FRET Channel (F): Ex/Em: 488/670 nm; PMT: 500 V

See Notes 13 and 14 for further details on scanning and qualitative analysis of
the plate. See sample plate scan in Fig. 2A, bottom panel.

11Single Site ex: PARP-1 + Nuc146; Quadratic ex: PARP-1 + Nuc165. To start, probe concentrations should be around 2–3 nM. Probe
concentrations can be increased based on signal and expected KD.
12PMT values can be increased or decreased based on the concentration of the ligand and probes, or labeling efficiency.
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3.4.5 HIFI-FRET Data Analysis
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1.

Open scans (.ds file) from typhoon in ImageQuant TL.

2.

Use the array analysis to quantify each well in the plate. Use the buffer-only
wells as a background (negative) control.

3.

Export the data from the acceptor, donor, and FRET channels to Microsoft Excel.

4.

Calculate the direct excitation by the acceptor (χA) by using Equation 2.1.
Average the direct excitation values for each titration point.

5.

Calculate the donor bleed through (χD) by using Equation 2.2. The first two
wells in each FRET series are donor only controls (0 nM ligand). Average the
donor bleed through (4 values) per probe used.

Author Manuscript

Equation 2
6.

Calculate the FRET corrected (FRETcorr) by using Equation 3. The direct
excitation value (χA) must correspond to each titration point, while the donor
bleed through (χD) is a single number per probe used. F#, A#, and D# are values
for the FRET series (P+L).
Equation 3

Author Manuscript

7.

Graph the FRET corrected values in GraphPad Prism using the ligand titration
series as X-axis values and FRET corrected on Y-axis.

8.

If the probe concentration, [P], is 5× below the KD, analyze the data with the
single site binding equation (Equation 4). If the probe concentration is less than
5× below the KD and multiple probe concentrations were used, analyze the data
with the quadratic equation to yield a global KD (Equation 5). Use the numerical
value of probe concentration (e.g. ‘5’ for a 5 nM probe) to label each Y-column.
See Note 15 for further details on data analysis.

Equation 4

Author Manuscript

13If splotches or swirls appear in the well, the protein and ligand may have aggregated. In this case, buffer conditions may need to be
re-optimized or plates will need to be freshly treated.
14Speckles can occur in automodified Parp samples, but should not affect data analysis and resulting apparent K . Speckles can be
D
eliminated by spinning the sample at 10k rpm for 10 minutes prior to adding probe to the microplate.
15The binding curve must reach an upper plateau to obtain reliable binding constants. Likewise, the beginning of the binding curve
needs to exhibit a baseline.
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Equation 5

3.4.6 Job Plot Plate Set Up

Author Manuscript

1.

Clean the bottom of the microplate glass with H2O, followed by EtOH, followed
again by H2O, wipe dry with using lint-free kimwipes.

2.

Dilute the donor labeled PARP-1 and acceptor labeled ligand (nucleosomes or
DNA) into a master stock that is 2× the final concentration (e.g. 2000 nM master
stock for a 1000 nM titration series).

3.

Set up two titration series. First, in the donor labeled Parp series, Parp will
increase in incremental steps (e.g. 25 nM). Second, the acceptor labeled ligand
(nucleosomes or DNA) will decrease in the same incremental step (See Note 16).

4.

In duplicate, add 20 µL acceptor (ex: Nuc165) titration series followed by 20 µL
donor (ex: PARP-1) titration series to the treated microplate.

5.

Add a buffer-only (40 µL buffer), acceptor only (20 µL acceptor + 20µL buffer),
donor only (20 µL donor + 20 µL buffer) to the plate in duplicate. The bufferonly control serves as background correction, the acceptor only will yield an
averaged single direct excitation value, and the donor only will yield an averaged
single donor bleed through value.

3.4.7 Job Plot Plate Scanning

Author Manuscript

1.

Scan according to HIFI-FRET scanning protocol described above.

3.4.8 Job Plot Data Analysis

Author Manuscript

1.

Follow steps 1–6 for HIFI-FRET plate quantification in ImageQuant TL and use
equations 2.1, 2.2, and 3 to calculate FRET corrected (See Note 17).

2.

Plot FRET corrected (Y-values) against the molar ratio (X-values).

3.

The peak of the curve indicates the ideal molar ratio of Parp (χP) (See Note 18).

4.

In the case of DNA, the peak is 0.66. To calculate the stoichiometry, divide 0.66
Parp by 0.33 DNA to yield 2 PARP-1 to 1 DNA molecule. In the case of Nuc165,
the peak is 0.5 to yield a 1 to 1 ratio of PARP-1 per mononucleosome (See Notes
19 and 20).

16Increasing the donor and decreasing the acceptor in identical incremental steps maintains the overall molar ratio (protein to ligand)
equal to 1.
17Instead of a titration series of acceptor only (acceptor + buffer), here there will only be 1 value averaged from the two acceptor only
wells.
18Equation 6.1 (PL) would yield a peak at 0.5; P L (Equation 6.2) would yield a peak at 0.66; PL (Equation 6.3) would yield a peak
2
2
at 0.33.
19If the ideal molar ratio doesn’t equal a whole number, multiply the entire stoichiometry to yield a whole number. Ex: 0.33 peak
would yield 0.5 Parp to 1 ligand. Multiplying the stoichiometry by two would yield 1 Parp to 2 ligand (PL2).
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Equation 6

Equation 7

Author Manuscript

Equation 8

3.5 Size Exclusion Chromatography with Multi Angle Light Scattering (SEC-MALS)

Author Manuscript

Size exclusion chromatography coupled with multi-angle light scattering uses laser light
scattering to provide information about shape and size of pre-fractionated protein samples in
solution. Here, this method can be used to determine homogeneity, molecular weight, and
stoichiometry of various complexes (e.g. PARP-1 in complex with the mononucleosome).
Coupling MALS with SEC allows for species separation in solution as the species are eluted
separately off the column. However, one caveat with this method is that smaller than twofold differences in molecular weight cannot be detected (in these cases, AUC, described
below, would be a more appropriate method). In order to perform SEC-MALS experiments,
a HPLC system needs to run a suitable size exclusion column connected to a MALS and
refractive index (RI) detector. Here, we analyze PARP-1 interactions with a
mononucleosome assembled on 207 base pair DNA (Nuc207; Fig. 3A) (5). PARP-1 and the
nucleosome alone give rise to molecular weights within error of the theoretical molecular
weight. Combining equimolar amounts PARP-1 and Nuc207 yields a shift in elution, and a
molecular weight within 0.3% of the theoretical molecular weight of a 1:1 complex (Fig.
3A, Table). Adding excess PARP-1 yields a free PARP-1 peak and no further shift of the
complex peak illustrating the stoichiometry of PARP-1 for Nuc207 remains 1 to 1 (Fig. 3A,
Table).

Author Manuscript

1.

Prepare 120 µL of nucleosome solution at about 0.2–0.5 mg/ml and 120 µL of
Parp alone solution at ~2 mg/mL (use higher concentrations for smaller proteins)
(See Notes 21 and 22).

2.

Incubate desired titrations of Parp with nucleosome or DNA overnight in 120 µL
at 4°C.

20Unstable reducing agents such as DTT or BME, or other unstable buffer components such as detergents should be avoided. pHadjusted TCEP should be used as the reducing agent.
21Thoroughly dialyze or buffer exchange samples in the running buffer to avoid high background due to buffer differences.
22It is recommended that a BSA standard (2 mg/mL) be run as a control prior to testing samples.
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3.

Equilibrate the column with buffer pre-filtered through a 0.1 µm membrane (See
Note 23).

4.

Spin the sample at 14,000 rpm for 10 minutes and inject 100 µL into the SEC
column with a micro-syringe. Alternately a micro-filtration centrifugal device
can be used.

5.

Unicorn software is used to run the SEC, while the ASTRA software from Wyatt
records the MALS and RI data. Refer to the manufacturer manual for details.

3.6 Analytical Ultracentrifugation (AUC)

Author Manuscript

Sedimentation velocity is used to analyze particles in solution based on rate of
sedimentation. The analysis of sedimentation rates provides information on the size and
shape of the particle. Data collection should be collected in intensity mode rather than
absorbance to minimize noise levels (15). For further details on AUC methodology and set
up, see (7). Importantly, chromatin of various sizes (mono-, tri- or arrays) or Parp proteins
(e.g. PARP-1 or N-Parp) can be analyzed on their own or in combination. Here, we
demonstrate that PARP-1 and N-Parp (1–486) proteins are homogeneous species with Savg
(S20,w) values of 5S and 3.2S, respectively (Fig. 3B). Upon addition of mononucleosome
(Nuc165, Savg, 12S), S values shift to Savg 14S and 13S, respectively (Fig. 3C). The shift of
the mid-point S value confirms complex formation, while the homogenous shift indicates a
single population and single binding event. A similar phenomenon is also seen with NLE-Tri
(Savg 17S) in complex with N-Parp (Savg 21S) (Fig. 3D), although trinucleosomes and
trinucleosome/Parp complexes are more heterogeneous due to the flexible nature the
connecting linker DNA.

Author Manuscript
Author Manuscript

1.

Clean AUC cell components and assemble the cell (See Ref. (7) for more detail
and clarification).

2.

For Parps, nucleosomes, and complexes, ~0.3–0.4 sample absorbance (at 260 or
280 nm) in 400 µL volume is required for high-quality data. Dilute sample in
sample buffer (See Note 24).

3.

Prepare sample (for example, mono or tri-nucleosomes) in the final dialysis
buffer or the binding buffer and collect data in intensity mode. Use water in
reference channels.

4.

Rotor speed needs to be calibrated based on size of the particles in the sample.
The smaller size of the particle, the higher the speed needed to sediment it fully.
For example, mononucleosome samples (~220 kDa) should be spun at 40k rpm
while 30k rpm should be used for trinucleosome samples (~650 kDa).

5.

Data collection is dependent upon the number of scans representing the full
spectrum of sample sedimentation (from the top to the bottom of the cell). The

23Resolution power and lack of contaminations on the SEC column are essential to minimize light scattering background signal. Refer
to the manufacturer’s instruction for cleaning procedures. Leaching of particles from column results in an unstable baseline.
24Any buffer is compatible with AUC, but DTT above 1 mM should be avoided. BME and detergents should also be avoided due to
background scatter.
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number of scans depends on the molecular weight of the samples, the speed of
the rotor, the number of samples in the rotor, etc. (See Note 25).
6.

AUC data analysis is performed using the Ultrascan 3 software by following the
user manual details found here: http://www.ultrascan2.uthscsa.edu/manual2/
index.html (16–19).

3.7 Atomic Force Microscopy (AFM)

Author Manuscript

Atomic force microscopy allows for low-resolution visualization of complexes, in addition
to providing estimates of volume and height. The measurement is based on the capacity of
the sample to reflect laser light off a cantilever during surface scanning. Here we describe
AFM data collection in air to allow for rapid direct visualization of complexes, e.g. PARP-1
in complex with trinucleosomes (Fig. 4) (3). The approach is particularly powerful if used
with defined nucleosomal arrays (7, 20, 21). In this case, the 1×1 µm scan images obtained
with NLE-Tri indicates three nucleosomes held together by linker arms with a height profile
of ~1.5–2 nm (Fig. 4A). The addition of PARP-1 shows compaction of the NLE-Tri as
indicated by a height profile increase to 3–5 nm (Fig. 4B). This compaction is alleviated
when PARP-1 is automodified, as the height profiles return to 1.5–2 nm (Fig. 4C).
2.7.1 Procedure

Author Manuscript
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1.

Use scotch tape to cleave mica. Press tape down on the mica disc and peel off
repeatedly to ensure that a smooth mica surface is obtained. Modify freshly
cleaved mica with APTES by adding 30 µL of a 1 in 1000 dilution in water onto
the mica disc. Incubate the covered disc for 30 minutes at room temperature.
Rinse the disc with 0.2 µm filtered water and gently dry using a pure nitrogen
stream.

2.

Dilute the sample using sample buffer. For example, trinucleosome samples are
diluted to ~1.5 ng/µL but dilution range depends on sample.

3.

Pipette 30 µL of the diluted sample onto the APTES-mica disc and let stand for
5–15 min.

4.

Rinse the disc surface with sample buffer, and gently dry with pure nitrogen or
compressed air.

5.

Wipe off any residual buffer droplets from the sample area and place the slide on
the microscope stage. Secure the stage with magnets.

6.

Begin scanning the sample area with 5 × 5 µm areas. Once well-spread areas are
identified, narrow the scope to 2 × 2 µm scans. Increase resolution to 1 ×1 µm
scans and continue to increase resolution if the instrument is capable. However,
at higher resolution scans (i.e. smaller areas), the noise will increase due to the
high sensitivity.

25Generally, 150 scans should be collected per sample.
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2.7.2 AFM Data Processing
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1.

Images from the data collection are ‘flattened’ and analyzed using MFP-3D
software (Asylum) or a comparable software.

2.

Each 1×1 µm image in Fig. 4 was divided into four quadrants and zoomed in
digitally to obtain a clear view trinucleosomes.

3.

Multiple free hand lines were drawn through the particles to obtain height
profiles (Fig. 4; insets on right side) For statistical analysis, a large number of
images should be analyzed (See Note 26).

3.8 Small Angle X-Ray Scattering (SAXS)

Author Manuscript
Author Manuscript

Small angle x-ray scattering is used to obtain low resolution size and shape information on
individual proteins or protein complexes. Data is collected at a synchrotron equipped with
SAXS beamlines (e.g. APS Chicago – BioCAT, Sector 18ID). SAXS data collection should
ideally be coupled with size exclusion chromatography (SEC-SAXS) (22). The addition of
SEC separates any free chromatin components from the sample prior to SAXS data
collection. We need to have a q-range suitable for larger macromolecules such as the monoand trinucleosome complexes. The approximate qmin required to study any given
macromolecule is considered to be π/Dmax. Here, we show SEC-SAXS analysis of radiation
of gyration (Rg) and maximum dimension (Dmax) for the mononucleosome and the
nucleosome in complex with N-Parp (Fig. 5). The data indicates the mononucleosome alone
yields a spherical envelope (Rg: 47Å; Dmax 157Å) (Fig. 5B) (23, 24). The N-Parp and
mononucleosome complex shows an increase in dimension; however, while the Rg and Dmax
values are not additive, the values are larger than the nucleosome indicative of binding (Rg:
55Å; Dmax 194Å) (Fig. 5C and D).

Author Manuscript

1.

Write a proposal requesting beam time. Proposal submission procedures and
deadlines can be found on beamline web sites.

2.

Concentrate individual samples (e.g. N-Parp and Nuc165) to ~2 mg/mL in ~150
µL in low binding Eppendorf tubes. Save an aliquot pre- and post-concentration
for examining the complexes by other methods (such as EMSA and AUC, see
above).

3.

Samples must be prepared and shipped to the beamline a day or two in advance.
For Parp samples, ship on dry ice to maintain −80°C. Chromatin samples should
not be frozen. Instead, make an ice pack by filling Ziploc bags with ice and place
samples sealed in 50 mL falcon tubes inside.

4.

Arrive at the beamline the night before for wet lab set up, such as preparation of
buffers and any complexes (e.g. N-Parp + mononucleosomes). Set up Parp
complexes as described above.

5.

Complete SAXS data collection for individual components as well as complexes
(See Notes 27 and 28).

26Microsoft Excel can be used to analyze results for easy visualization and comparison of images.
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6.

Clean the quartz sample chamber after each run using a Hamilton Syringe Pump
sequentially with water, bleach, water, isopropanol, and water to prevent cross
contamination between runs.

7.

Data-reduction (radial averaging of the scattering intensities to generate I (q) vs q
plots), usually involves software indigenous to the beam line and should be done
at the beamline. Subtract buffer from sample data.

8.

All further data processing can be done with the ATSAS suite. Rg and Dmax can
be determined by Primus in ATSAS (25).

9.

Ab initio modelling is done using Dammin (26).

10.

Images of the envelopes can be generated in VMD by first generating a shell in
pdb2vol (27–29).

Author Manuscript
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Figure 1. PARP-1 – chromatin interactions analyzed by native PAGE
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A. PARP-1 is a multi-domain protein. The N-Parp construct used here is composed of
residues 1–486.
B. Schematic of mononucleosomes and trinucleosomes used in assays discussed here.
Nuc146 and NLE-Tri do not have exposed DNA linker ends, while Nuc165 and Nuc207 do.
C. Schematic for preparing automodified and ‘mock-automodified’ PARP-1. Pre-quenching
with a Parp inhibitor (PJ34) prior to addition of DNA and NAD+ inhibits the NAD+ binding
site in PARP-1. Automodified PARP-1 samples are quenched with PJ34 after incubation
with DNA and NAD+. Each probe has the same reaction components to ensure binding
affinity differences are due to PARylation.
D. PAGE analysis of Alexa-488 fluorescently labeled PARP-1. PARP-1, pre-quenched
PARP-1 (pQ), and automodified PARP-1 (AM) were run on a denaturing PAGE. Left:
Protein stain of 1 µg unlabeled PARP-1 reactions. Lane 1, molecular weight marker; Lane 2,
PARP-1 alone; Lane 3, pre-quenched PARP-1; Lane 4, automodified PARP-1. Middle:
Protein stain of 1 µg Alexa488 labeled PARP-1. Lane 1, molecular weight marker; Lane 2,
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PARP-1 alone; Lane 3, pre-quenched PARP-1; Lane 4, automodified PARP-1. Right: Cy2
(ex/em: 473/520 nm) typhoon scan of 0.25 µg Alexa488 labeled PARP-1. Lane 1, prequenched PARP-1; Lane 2, automodified PARP-2; Lane 3, molecular weight marker. Both
unlabeled and labeled PARP-1 samples show a single homogenous band (with less than 5%
degradation), while automodification (AM) creates a heterogeneous smear or shifted band
on the gel due to PARylation.
E. EMSA analysis of PARP-1, unlabeled and Alexa488 labeled, with unlabeled and
Atto-547N labeled mononucleosomes. Nuc165 was incubated with PARP-1 (0.5, 1, and 1.5fold excess) and analyzed on a 5% TBE-PAGE. Gels were stained as indicated. FL-PARP-1
binding to mononucleosomes results in a supershifted band. Addition of a fluorescent label
to PARP-1 and Nuc165 does not effect this interaction. Lane 1, molecular weight marker;
Lane 2, 165 bp DNA; Lane 3, unlabeled Nuc165; Lane 4–6, increasing titrations of
unlabeled PARP-1 with unlabeled Nuc165; Lane 7, Atto-647N labeled Nuc165; Lane 8–10,
increasing titration of Alexa488 labeled PARP-1 with Atto-647N Nuc165.
F. EMSA analysis of N-Parp with NLE-Tri. NLE-Tri was incubated with N-Parp (0.8, 1, 1.2,
1.4, 1.6, and 1.8-fold excess) and analyzed on 1% agarose. Gels were stained as indicated.
N-Parp binding to trinucleosomes resulted in band of slower mobility. Lane 1, Molecular
weight marker (1kb); Lane 2, NLE-Tri alone; Lanes 3–8, increasing titration of N-Parp (0.8–
1.8) with NLE-Tri; Lane 9, NLE-Trimer DNA (561 bp). Samples from lanes 2 and 6 were
used in the AUC experiments in Figure 3D.
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Figure 2. HIFI-FRET binding & Job plot stoichiometry assays
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A. Schematic of HIFI-FRET binding assays (top) and representative FRET plate typhoon
scans (bottom). Donor probe (e.g. PARP-1) is kept constant while acceptor ligand (e.g.
Nuc165) is titrated. Acceptor only (acceptor + buffer) in the top two rows; donor only (donor
+ only) in the first two wells in the FRET series. Interaction between the two binding
partners yields FRET.
B. A representative binding curve of PARP-1 binding mononucleosomes with and without
DNA linker ends. PARP-1 binds Nuc146 (□, dashed line) with weak affinity (> 500 nM) and
no saturatable plateau. PARP-1 binds Nuc165 (●) with low nanomolar affinity (~2 nM).
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C. Representative binding curve for Pre-Quenched PARP-1 (pQ) (●) and AM-PARP-1 (□,
dashed line) to NLE-Tri. PARP-1 binds tightly to NLE-Tri (~5 nM); the affinity weakens 20fold when PARP-1 is automodified (~101 nM). Note that panel 2C is reused from a previous
publication (3).
D. Schematic of Job plot stoichiometry experimental set up (top) and representative plate
typhoon scans (bottom). The donor probe (here, PARP-1) is incrementally increased while
acceptor ligand (here, Nuc165) is incrementally decreased keeping the overall molar ratio
equal to one. Interaction between the two binding partners yields FRET signal.
E. Representative Job plot stoichiometry curve for PARP-1 binding double stranded DNA
(●) and mononucleosomes (□). The dashed lines indicate the peak of each curve and the
ideal molar ratio. At a peak of 0.5, PARP-1 binds Nuc165 in a 1 to 1 stoichiometry. DNA
binds two PARP-1 molecules (peak of 0.66).
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Figure 3. Solution state analysis of PARP-1 binding mono- and tri-nucleosomes
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A. Analysis of PARP-1 binding mononucleosomes via size exclusion coupled multi-angle
light scattering. Nuc207 forms a 1:1 complex with PARP-1 even when excess PARP-1 is
added. The molecular weights for the various complexes derived are listed in the table. Note
that panel 3A figure and table are reused from (5).
B. Analysis of PARP-1 by AUC. Sedimentation velocity profile for N-Parp (□) indicates an
Savg value of ~3.2S and ~5S for full length PARP-1 (○). The vertical nature of the G(s) plot
indicates homogeneity of the protein samples.
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C. Analysis of PARP-1 interaction with mononucleosomes via AUC. Sedimentation velocity
profile for Nuc165 (○, gray) gives rise to an Savg of ~12S, complex formation with N-Parp
(□) results in a shift of the complex Savg to ~13S; and full length PARP-1 (Δ) interaction
with nucleosomes shifts the Savg to ~14S.
D. Analysis of N-Parp tri-nucleosome complexes via AUC. Sedimentation velocity profile
for NLE-Tri (●, gray) has an Savg of ~17S, interaction with N-Parp (■) results in an Savg of
~21S.
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Figure 4. Atomic force microscopy of trinucleosomes and PARP-1 trinucleosome complexes
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A, B, C. AFM of NLE-Tri and PARP-1 NLE-Tri complexes. 1–1.5 µm scans are shown here.
A. NLE-Tri alone; B. NLE-Tri + PARP-1; C. NLE-Tri + automodified PARP-1 (AMPARP-1). Height profiles of selected particles are shown underneath each image. In the
absence of PARP-1, trinucleosomes have a height profile of 1.5–2 nm but in the presence of
PARP-1, the trinucleosomes are compacted (height profiles increase to 3–5 nm).
Compaction is alleviated by automodification of PARP-1 and release from chromatin (height
profiles similar to no PARP-1). Note that panels 4A-C are reused from a previous
publication (3).
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Figure 5. Small angle x-ray scattering (SAXS) of N-Parp – mononucleosome complex
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A. SAXS data for the mononucleosome. Left panel - Guinier plot for data acquired for
Nuc165 indicates a radius of gyration (Rg) of 47 Å. Right panel - P (R) function plot for
Nuc165 indicates a maximum dimension (Dmax) of ~157 Å.
B. SAXS data for N-Parp mononucleosome complex. Left panel - Guinier plot for Nuc165N-Parp complex indicates an Rg of ~55 Å. Right panel - P (R) function plot for
mononucleosomes indicates a Dmax of ~194 Å.
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C. Overlay of the normalized P(R) function plot for Nuc165 (■, gray) and N-Parp+Nuc165
complex (●, black). Shift is indicative of an increase in size potentially indicative of PARP
binding.

Author Manuscript
Author Manuscript
Author Manuscript
Methods Mol Biol. Author manuscript; available in PMC 2018 January 01.

Chassé et al.

Page 27

Table

Author Manuscript

Observed MW

Calculated MW

Error

Nuc207

2.45 × 105

2.36×105

3.7%

PARP-1

105

105

2.7%

1.10 ×

1.13 ×

Nuc207+ PARP-1(1:1)

3.50 × 105

3.49 × 105

0.3%

Nuc207+PARP-1 (1:2)

105

105

24.2%

3.50 ×

4.62 ×
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